Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01656954 · ClinicalTrials.gov registry record
Predicting Volume Response Study
A clinical trial of Shock and Hypovolemia, sponsored by University of Pennsylvania.
- Completed
- Registry status
- 7
- Enrollment target
- 1
- Study location
NCT01656954 is a study of Shock and Hypovolemia that has completed, run by University of Pennsylvania. The registered enrollment target is 7 participants, below the 481-participant average among 9 other Shock trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state.
The verdict
NCT01656954, a study of Shock and Hypovolemia, has completed, sponsored by University of Pennsylvania.
- COMPLETED
- Registry status
- 7 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to understand and document measurements in heart stroke volume (the volume or amount of blood pumped per heart beat) and cardiac output (the volume or amount of blood pumped by your heart per minute) during a passive leg raise maneuver (elevation of the legs), and to determine if these measurements can predict changes in the same as a result of fluid or blood product administration.
Conditions Studied
Interventions
- PROCEDURE Passive Leg Raise (PLR)
Study Locations (1)
Pennsylvania
- Hospital of the University of Pennsylvania - Philadelphia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 7 participants |
| Start Date | 2011-08 |
| Est. Completion | 2014-04 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01656954
The ClinicalTrials.gov registry entry for NCT01656954 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 7 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 481-participant average among 9 other Shock trials with a reported enrollment target (99% lower). The listed sponsor is University of Pennsylvania, which has 1,423 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Shock appearing as the primary indexed condition, and to 1 intervention - of which Passive Leg Raise (PLR) is the first listed.
NCT01656954 reports 1 study location spanning 1 distinct geographic area - top geographies include Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT01656954 about?
NCT01656954 is a clinical study titled "Predicting Volume Response Study". The purpose of this study is to understand and document measurements in heart stroke volume (the volume or amount of blood pumped per heart beat) and cardiac output (the volume or amount of blood pumped by your heart per minute) during a passive leg raise maneuver (elevation of the legs), and to det...
What is the current status of trial NCT01656954?
This trial is currently completed. The enrollment target is 7 participants. The study started on 2011-08. Estimated completion is 2014-04.
What conditions does trial NCT01656954 study?
This clinical trial studies the following conditions: Shock, Hypovolemia.
What interventions are being tested in trial NCT01656954?
The interventions under investigation include: Passive Leg Raise (PLR) (PROCEDURE).
Who is sponsoring clinical trial NCT01656954?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01656954 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Shock
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Assessment of Stroke Volume in Shock Using Echocardiography Versus Bioreactive Impedance
RECRUITING
-
Resuscitative TEE Collaborative Registry
RECRUITING
-
Evaluating Fluid Responsiveness in ICU Patients Using VTI and Trendelenburg Positioning
RECRUITING · NA
-
Central Line Study
RECRUITING · Phase 4
-
Vasoactive Drugs in Intensive Care Unit
RECRUITING · Phase 4
-
Hemodynamic Response to Angiotensin-II When Used as the Second Vasopressor Agent for Septic Shock
RECRUITING · Phase 4
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.